Global Development Lead (GDL) , Clinical Development – GI Cancers

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company is seeking an experienced oncology drug-development leader to serve as Global Development Lead (GDL) for one of its most advanced clinical programs.

Requirements

• Medical degree (MD) with board certification in Medical Oncology or Hematology/Oncology
• Depth of experience in oncology clinical development, typically gained at least 13 years
• Leadership of global, late-stage development programs, including design and execution of pivotal Phase 2/3 studies
• Experience owning or leading global regulatory strategy, including direct involvement in multiple interactions with global health authorities
• Experience contributing to or leading regulatory submissions (NDA/BLA/MAA)
• Excellent written and verbal communication skills
• Ability to travel approximately 25–30%
• San Francisco Bay Area preferred, but hybrid acceptable

Benefits

• Competitive cash compensation
• Robust equity awards
• Strong benefits
• Significant learning and development opportunities